Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell

Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.

1,618 public trials 340 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell trial results

Completed

A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT02760485

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Pacific Shores Medical Group Long Beach, California, United States
  • LAC-USC Medical Center/Kenneth Norris Jr Cancer Hospital Los Angeles, California, United States
View all 21 locations
View Trial Details
Completed

Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma

NCT00003615

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • CCOP - Southern Nevada Cancer Research Foundation Las Vegas, Nevada, United States
  • Trinitas Hospital - Jersey Street Campus Elizabeth, New Jersey, United States
View Trial Details
Completed

A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma

NCT03003520

Conditions
Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +11 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Parkview Research Center Fort Wayne, Indiana, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View all 20 locations
View Trial Details
Completed

S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia

NCT01925131

Conditions
Acute Leukemias of Ambiguous Lineage, B-cell Adult Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +24 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • University of Rochester Rochester, New York, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
View Trial Details
Completed

Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

NCT01092182

Conditions
Blood-Borne Infections, Burkitt Lymphoma, Communicable Diseases, +29 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Center for Clinical AIDS Research and Education Los Angeles, California, United States
  • Emory University /Winship Cancer Institute Atlanta, Georgia, United States
  • University of Illinois Chicago, Illinois, United States
View all 30 locations
View Trial Details

Related conditions